Strand Therapeutics
Signal active
Organization
Contact Information
Overview
Strand Therapeutics is a developer of a biotechnology platform intended to create gene therapies powered by synthetic biology.The company's offerings include immunotherapies to help cells produce target cancer-killing proteins during immunotherapy, enabling patients to improve their body's immune system to fight cancer.
About
Industries
Biotechnology, Life Science, Pharmaceutical, Therapeutics
Founded
2017
Employees
101-250
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Strand Therapeutics headquartered in United States, North America, operates in the Biotechnology, Life Science, Pharmaceutical, Therapeutics sector. The company focuses on Biotechnology and has secured $10.0B in funding across 96 round(s). With a team of 101-250 employees, Strand Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Series A - Strand Therapeutics, raised $45.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
6
Investors
4
Lead Investors
0
Total Funding Amount
$104.2M
Details
3
Strand Therapeutics has raised a total of $104.2M in funding over 3 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2019 | Seed | 6.0M | ||
| 2021 | Early Stage Venture | 52.0M | ||
| 2022 | Early Stage Venture | 45.0M |
Investors
Strand Therapeutics is funded by 27 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Jory Bell | - | FUNDING ROUND - Jory Bell | 45.0M |
| Playground Global | - | FUNDING ROUND - Playground Global | 45.0M |
| Strand Therapeutics | - | FUNDING ROUND - Strand Therapeutics | 45.0M |
| Potentum partners | - | FUNDING ROUND - Potentum partners | 45.0M |
Recent Activity
There is no recent news or activity for this profile.